The term express is still in use today, and is applied to rifles, ammunition, and a type of iron sight. With the widespread adoption of small bore, high velocity rifle cartridges, the meaning of express has shifted in modern usage, and refers to high velocity, large bore rifles and ammunition, typically used for hunting large or dangerous game at close range.
The name originates with a rifle built by James Purdey in 1856 (based on a pattern established a year earlier by William Greener) and named the Express Train, a marketing phrase intended to denote the considerable velocity of the bullet it fired. It was not the first rifle or cartridge of this type but it was Purdey's name express that stuck.
The Ekspress series of communication satellites (industry code 11F639) was developed by the satellite company NPO PM as a replacement for the old Gorizont series of comsats. The first satellite of the series, Ekspress 1, was launched in 1994. It had a mass of 2.5 tons, 17 channels and an operational lifetime of at 5–7 years.
Starting in the mid-1990s, NPO PM started to make significant effort to close the technology gap between Russian and Western communication satellites. Cooperation with the French company Alcatel (now Thales Alenia Space) was begun in 1995. The first satellite of a new second series, Ekspress A-1, had 12 Alcatel-built transponders. It was lost in a rocket failure in 1999, but a replacement, Ekspress A-2 was successfully launched in March, 2000.
“The funds allowed us to expand programming and offer more opportunities for participants to express their diverse abilities, challenges and interests through art and music,” Venture said in a press release ... ....
This press release contains forward-looking ... These and other factors that may cause Harpoon Therapeutics’ actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Harpoon Therapeutics’ filings with the U.S.
The publication outlines data from a study, conducted in collaboration with researchers in the Department of Pathology at Yale School of Medicine, utilizing a newly developed antibody to Siglec-15 (S15) and an immunhistochemical (IHC) assay to investigate S15 expression in solid tumors.
Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release relating to the Company may be found in the Company's periodic filings with the Securities and Exchange Commission, ...
It says of freedom of expression that “ (1) Everyone has the right to freedom of expression, which includes (a) freedom of the press and other media; (b) freedom to receive or impart information or ideas; (c) freedom of artistic creativity; and (d) academic freedom and freedom of scientific research”.
... the current vaccine distribution, the adverse effect of the Omicron variant, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995... All statements other than statements of historical facts contained in this press release may be forward-looking statements ... The forward-looking statements in this press release are only predictions.
Detailed information regarding the factors identified by the Company’s management which they believe may cause actual results to differ materially from those expressed or implied by such forward-looking statements in this press release may be found in the Company’s filings with the U.S.
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements.
As Nolan Higdon (5/28/22) pointed out, “You Can Kill and Censor Journalists or You Can have Democracy—You Can’t Have Both!” Such attitudes toward Israeli repression of Palestinian expression are a major contradiction by US media institutions, which themselves enjoy press freedoms ...